Public consultation on applications to be considered by the MSAC PASC (December 2022)

Overview

Consultation is now open for applications that are anticipated to be considered by the PICO Advisory Sub-Committee (PASC) of the Medical Services Advisory Committee (MSAC) on 8-9 December 2022.

PASC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies being addressed by the application.   

It is anticipated that the below-mentioned applications will proceed to PASC in December 2022. Consultation input must be received by no later than Friday, 4 November 2022 for it to be considered by PASC. A consultation survey form is available on the relevant application webpage.

Further information on MSAC’s consultation process is also available on the MSAC website.

Applications scheduled to be considered:

1712 – Out-of-laboratory sleep studies in the diagnosis and management of sleep disordered breathing in children & adolescents

1725 – Transanal total mesorectal excision for the treatment of rectal cancer and benign disease

1727 – Deep brain stimulation for treatment-refractory obsessive compulsive disorder

1732 – Imlifidase as a desensitisation treatment to enable kidney transplant in highly sensitised adult transplant candidates

1736 – Lipoprotein(a) testing as an independent predictor of cardiovascular disease

1737 – Newborn bloodspot screening for Sickle Cell Disease and Beta Thalassaemia

What happens next

Once the consultation closes, all submissions received will be compiled and summarised in the draft PICO Confirmation and sets out the proposed parameters upon which the assessment is based.

The PASC meets to discuss the draft PICO Confirmation and the consultation comments that have been received.

Once the PICO Confirmation is ratified by the PASC, the PICO Confirmation is published on the relevant application webpage on the MSAC website.